2020 IPO

SutroVax Stock

SutroVax is a biopharmaceutical company

Sign up today and learn more about SutroVax Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About SutroVax Stock

SutroVax is a recently established biopharmaceutical company developing vaccines for infectious disease targets with an initial emphasis on best-in-class conjugate vaccines and protein-based vaccines. SutroVax is an independent company that was spun out of Sutro Biopharma with an exclusive license to Sutro Biopharma’s Xpress CF™ platforms for cell free protein synthesis and site-specific conjugation.

Funding History

July 2015$22.0M
March 2017$4.0M
March 2017$60.0M
June 2018$85.0M



Moncef Slaoui

Founder & CEO

Grant E. Pickering


EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: